Evidence map›Paper›PMID 40469430›Full record

ArticleJournal of cardiology cases2025

Amyloid and Anderson-Fabry disease: Can there be a CMR phenotypic overlap?

Saed Alnaimat, Mariah Mascara, Srijana Maharjan, Abdallah Naser, Valentyna Ivanova, Moneal Shah, Robert W W Biederman

Abstract readCase Reports
In one paragraph

Article in Journal of cardiology cases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Saed AlnaimatAllegheny General Hospital, Center of Cardiac MRI, Pittsburgh, PA, USA.
Mariah MascaraAllegheny General Hospital, Department of Internal Medicine, Pittsburgh, PA, USA.
Srijana MaharjanAllegheny General Hospital, Department of Internal Medicine, Pittsburgh, PA, USA.
Abdallah NaserAllegheny General Hospital, Department of Internal Medicine, Pittsburgh, PA, USA.
Valentyna IvanovaAllegheny General Hospital, Department of Cardiology, Pittsburgh, PA, USA.
Moneal ShahAllegheny General Hospital, Center of Cardiac MRI, Pittsburgh, PA, USA.
Robert W W BiedermanWest Virginia University School of Medicine, Morgantown, WV, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 53-year-old female had an atypical presentation of cardiac amyloidosis on cardiac magnetic resonance imaging. As opposed to the usual diffuse heterogenous late gadolinium enhancement (LGE) seen in cases of cardiac amyloidosis, the patient had localized LGE in the inferolateral left ventricular wall classically resembling Anderson Fabry's disease. However, other cardiac magnetic resonance features raised the suspicion for cardiac amyloidosis which was later confirmed by endomyocardial biopsy. This case highlights that cardiac amyloidosis can have atypical imaging features that may lead to incorrect diagnosis. Clinicians should maintain a high index of suspicion and pay attention to certain supportive findings such as atrial wall thickening, valve leaflet thickening, pericardial effusion, as well as abnormal strain pattern. Learning objectives: •Cardiac amyloidosis can have atypical imaging features and strain pattern that may lead to incorrect diagnosis.•Clinicians should maintain a high index of suspicion and pay attention to certain supportive findings such as atrial wall thickening, valve leaflet thickening, pericardial effusion, as well as abnormal strain pattern.

Indexed as

Cardiac amyloidosisCardiac magnetic resonanceMultimodality imagingStrain deformationTissue characterization

Identifiers

PMID40469430
PMCPMC12130847

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.